Digital Genome Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Digital Genome Market is segmented by Product (Sequencing and Analyzer Instruments, DNA/RNA Analysis kits, Sequencing Chips, Sequencing and Analysis Software, Sample Preparation Instruments, and Other Products), Application (Clinical (Reproductive health, oncology, and others), Forensics, Drug discovery and development, and other applications), End-user (Hospitals, Diagnostic centers, and Forensic labs, Research Institutes, Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America).

Digital Genome Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Digital Genome Industry Overview

The digital genome market is competitive with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are bioMérieux, Agilent Technologies, Inscripta, Inc., GE Healthcare, and Invitae Corporation.

Digital Genome Market Leaders

  1. bioMérieux

  2. Agilent Technologies

  3. Inscripta, Inc.

  4. GE Healthcare

  5. Invitae Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Agilent Technologies, Inscripta, Inc., bioMérieux, GE Healthcare, Invitae Corporation, GenMark Diagnostics, Inc., Illumina, NanoString Technologies, Inc.

Digital Genome Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?